These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7134029)

  • 21. Differential effect of vasopressin on open-field activity and passive avoidance behaviour following intracerebroventricular versus intracisternal administration in rats.
    Günther O; Kovács GL; Szabó G; Schwarzberg H; Telegdy G
    Acta Physiol Hung; 1988; 71(2):203-6. PubMed ID: 3389163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.
    Kalange AS; Kokare DM; Singru PS; Upadhya MA; Chopde CT; Subhedar NK
    Brain Res; 2007 Nov; 1181():10-20. PubMed ID: 17915196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociception vs motor effects of intrathecal vasopressin as measured by four pain tests.
    Thurston CL; Culhane ES; Suberg SN; Carstens E; Watkins LR
    Brain Res; 1988 Oct; 463(1):1-11. PubMed ID: 3196898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
    Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive effects of (+/-)-, (+)- and (-)-nefopam in mice.
    Fasmer OB; Berge OG; Jørgensen HA; Hole K
    J Pharm Pharmacol; 1987 Jul; 39(7):508-11. PubMed ID: 2886617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat.
    Easterling KW; Holtzman SG
    Psychopharmacology (Berl); 1998 Nov; 140(1):91-7. PubMed ID: 9862407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of antidiuretic and natriuretic effects of [8-lysine]vasopressin and [8-D-arginine]deaminovasopressin in conscious rats.
    Skopková J; Hrbas R; Barth T
    Endocrinol Exp; 1981; 15(2):129-38. PubMed ID: 6973460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analgesia following intraventricular administration of 2-deoxy-D-glucose.
    Bodnar RJ; Merrigan KP; Wallace MM
    Pharmacol Biochem Behav; 1981 Apr; 14(4):579-81. PubMed ID: 7232479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
    Calcagnetti DJ; Holtzman SG
    Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
    Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential actions of central alloxan upon opioid and nonopioid antinociception in rats.
    Lubin E; Bodnar RJ
    Pharmacol Biochem Behav; 1989 Nov; 34(3):511-6. PubMed ID: 2623009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central discriminative effects of morphine in rats: training via intracerebroventricular administration.
    Easterling KW; Holtzman SG
    Brain Res Bull; 2001 Dec; 56(6):545-51. PubMed ID: 11786240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinociceptive effects of intraventricular or systemic administration of vasopressin in the rat.
    Berntson GG; Berson BS
    Life Sci; 1980 Feb; 26(6):455-9. PubMed ID: 7374355
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice.
    Arts KS; Holmes BB; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):890-6. PubMed ID: 2005587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of O-alkylated lysine-vasopressins, inhibitors of the antidiuretic response to lysine-vasopressin.
    Larsson LE; Lindeberg G; Melin P; Pliska V
    J Med Chem; 1978 Apr; 21(4):352-6. PubMed ID: 650663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma vasopressin is not involved in footshock-induced analgesia in rats.
    Hamamura M; Onaka T
    Jpn J Physiol; 1988; 38(5):741-6. PubMed ID: 3221526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between vasopressin and food restriction on stress-induced analgesia.
    Wideman CH; Murphy HM; McCartney SB
    Peptides; 1996; 17(1):63-6. PubMed ID: 8822511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of central versus peripheral opioid receptors in analgesia induced by repeated administration of opioid antagonists.
    Walker MJ; Lê AD; Poulos CX; Cappell H
    Psychopharmacology (Berl); 1991; 104(2):164-6. PubMed ID: 1652143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of hyperglycemic hyperalgesia by quinpirole.
    Roane DS; Paul D
    Pharmacol Biochem Behav; 1992 Jan; 41(1):65-7. PubMed ID: 1347178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.